Literature DB >> 15779510

Transfusion-associated graft-versus-host disease in an immunocompetent individual following cardiac surgery.

Kivanc Serefhanoglu1, Hale Turan, Tonguc Saba, Ismail Ozer, Emine Tosun, Hande Arslan.   

Abstract

A 65-year-old man underwent coronary artery bypass graft surgery at our tertiary care hospital. Perioperatively, he was transfused with four units of nonirradiated whole blood from first-degree relatives and discharged from the hospital at postoperative day seven. He presented six days later with fever, skin rash, elevated liver enzymes, and progressive pancytopenia. Elevated bilirubin levels and diarrhea were added to the clinical picture over the following days. Clinical findings and results of a skin biopsy specimen were consistent with transfusion-associated graft-versus-host disease. The patient died 20 days after transfusion.

Entities:  

Mesh:

Year:  2005        PMID: 15779510      PMCID: PMC2568630     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  11 in total

Review 1.  Transfusion associated graft-versus-host disease, cytomegalovirus infection and HLA alloimmunization in neonatal and pediatric patients.

Authors:  H A Hume; J B Preiksaitis
Journal:  Transfus Sci       Date:  1999-08

Review 2.  Transfusion-associated graft-versus-host disease.

Authors:  Marlis L Schroeder
Journal:  Br J Haematol       Date:  2002-05       Impact factor: 6.998

3.  Risk of transfusion-associated graft-versus-host disease as a result of directed donations from relatives.

Authors:  H Ohto; H Yasuda; M Noguchi; R Abe
Journal:  Transfusion       Date:  1992-09       Impact factor: 3.157

Review 4.  Survey of transfusion-associated graft-versus-host disease in immunocompetent recipients.

Authors:  H Ohto; K C Anderson
Journal:  Transfus Med Rev       Date:  1996-01

5.  Early diagnosis and successful treatment of a patient with transfusion-associated GVHD with autologous peripheral blood progenitor cell transplantation.

Authors:  Kendra Hutchinson; Patricia M Kopko; Kathryn N Muto; Joseph Tuscano; Robert T O'Donnell; Paul V Holland; Carol Richman; Teresa G Paglieroni; Theodore Wun
Journal:  Transfusion       Date:  2002-12       Impact factor: 3.157

6.  Transfusion-associated graft-versus-host disease with transfusion practice in cardiac surgery.

Authors:  K Yasuura; H Okamoto; A Matsuura
Journal:  J Cardiovasc Surg (Torino)       Date:  2000-06       Impact factor: 1.888

Review 7.  Transfusion-associated graft-versus-host disease in immunocompetent patients: report of a fatal case associated with transfusion of blood from a second-degree relative, and a survey of predisposing factors.

Authors:  L D Petz; L Calhoun; P Yam; M Cecka; G Schiller; A R Faitlowicz; R Herron; D Sayah; R B Wallace; A Belldegrun
Journal:  Transfusion       Date:  1993-09       Impact factor: 3.157

8.  Transfusion associated graft versus host disease in an immunocompetent individual following coronary artery bypass grafting.

Authors:  R Ahya; J G Douglas; H G Watson
Journal:  Heart       Date:  1998-09       Impact factor: 5.994

9.  Transfusion-associated graft vs. host disease after donor-specific leukocyte transfusion before kidney transplantation.

Authors:  Barbara J van der Mast; Marinus A van den Dorpel; Jos J M Drabbels; Frans H J Claas; Willem Weimar
Journal:  Clin Transplant       Date:  2003-10       Impact factor: 2.863

10.  Transfusion-associated graft-versus-host disease in immunocompetent patients: a self-protective mechanism.

Authors:  B J van der Mast; N Hornstra; M B Ruigrok; F H Claas; J J van Rood; E L Lagaaij
Journal:  Lancet       Date:  1994-03-26       Impact factor: 79.321

View more
  3 in total

1.  Recommendations on Selection and Processing of RBC Components for Pediatric Patients From the Pediatric Critical Care Transfusion and Anemia Expertise Initiative.

Authors:  Nicole D Zantek; Robert I Parker; Leo M van de Watering; Cassandra D Josephson; Scot T Bateman; Stacey L Valentine; Meghan Delaney
Journal:  Pediatr Crit Care Med       Date:  2018-09       Impact factor: 3.624

2.  INTERCEPT Pathogen Reduction in Platelet Concentrates, in Contrast to Gamma Irradiation, Induces the Formation of trans-Arachidonic Acids and Affects Eicosanoid Release during Storage.

Authors:  Gerda C Leitner; Gerhard Hagn; Laura Niederstaetter; Andrea Bileck; Kerstin Plessl-Walder; Michaela Horvath; Vera Kolovratova; Andreas Tanzmann; Alexander Tolios; Werner Rabitsch; Philipp Wohlfarth; Christopher Gerner
Journal:  Biomolecules       Date:  2022-09-07

3.  Prevention of transfusion-associated graft-versus-host disease by irradiation: technical aspect of a new ferrous sulphate dosimetric system.

Authors:  Lucas Sacchini Del Lama; Evamberto Garcia de Góes; Paulo César Dias Petchevist; Edson Lara Moretto; José Carlos Borges; Dimas Tadeu Covas; Adelaide de Almeida
Journal:  PLoS One       Date:  2013-06-07       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.